The genomic revolution has been facilitated by the convergence of minimally invasive diagnostic and therapeutic techniques, refinements in imaging and guided biopsy (particularly fine-needle aspiration biopsy), the development of whole genome sequencing, and the emergence of targeted therapies. Cytopathologists are the first responders from laboratories: they are educated to acquire, triage, and assess small biopsies and cell samples as substrates for molecular testing, next-generation sequencing, fluorescence in situ hybridization, immunohistochemistry, and genetic testing. Pathologists and cytopathologists are now integral to multidisciplinary care teams and have a voice in patient assessments for treatment plans. Cytopathologists who perform fine-needle aspiration biopsy (particularly ultrasound-guided biopsy) are at the direct interface with patients and are, of necessity, developing communication skills that incorporate empathy and compassion.Information transfer in the digital age has been complicated by information overload, a phenomenon that creates an opportunity for cytopathologists to become mentors in making sense of information (the process of information diffusion) and managing overload by serving as information professionals who guide learners to appropriate information resources.As cytopathologists migrate toward the center of patient care through interventional interfaces with patients, we become responsible for generating a complete, integrated report that moves information to patient portals on the Internet and to clinicians by secure digital delivery methods. With 70% of the medical record representing laboratory information, it is critical that pathologists take responsibility for its accuracy, display, and integration.This supplement, The Genomic Revolution: The Critical Role of Cytopathology in Patient-Centered Care and Personalized Medicine, was conceived to unite current research and procedural protocols with real-world clinical processes, from the clinical encounter with the patient to the quality assessment of the final report, and it is intended to provide an in-depth snapshot of why cytopathology is essential and integral to patient-centered care in the genomic era.Dr. Edward J. Gutmann, working in the pathology department of the Dartmouth-Hitchcock Medical Center (Dartmouth's Geisel School of Medicine), addresses caring for the patient in the context of cytopathology: "The diagnoses we make via the conscientious applications of specialized knowledge" represent how we care, and "the right diagnosis communicated well to patient and clinician can light the route even as it establishes it."1 Subliminally permeating his narrative exposition are the compassion and empathy that must characterize interactions with patients and communications with and about them. Caring implies and necessitates a culture of safety with metrics-based analysis of performance variation; root causes; error reporting, detection, and reduction; repair and adverse event management; and general quality initiatives. ...